Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Revenio: Holistic value creation on the horizon

REG1VExtensive research2023-03-20 14:15
Inderes
Discuss
Download report (PDF)

Under the iCare brand, Revenio offers world-class tonometers, fundus imaging devices and perimeters. In recent years, the company has added software solutions to its offering, moving from being an equipment provider to a holistic eye diagnostics solution provider. The core business is growing very profitably, the market has sound growth drivers, and the company’s products have strong competitive advantages. At the same time, the company is creating future growth by developing new growth initiatives, of which Revenio has an excellent track record.

Revenio is a global provider of comprehensive eye care diagnostic solutions. The group offers fast, user-friendly, and reliable tools for diagnosing glaucoma, diabetic retinopathy, and macular degeneration (AMD). Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as software solutions under the iCare brand. In 2023, the Group’s net sales totaled EUR 96.6 million, with an operating profit of EUR 26.3 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Read more on company page

Key Estimate Figures2023-03-18

202223e24e
Revenue97.0111.4129.6
growth-%23.1 %14.9 %16.3 %
EBIT (adj.)30.934.039.5
EBIT-% (adj.)31.8 %30.5 %30.5 %
EPS (adj.)0.860.981.15
Dividend0.360.420.55
Dividend %0.9 %2.6 %3.4 %
P/E (adj.)44.616.714.3
EV/EBITDA30.611.29.2

Forum discussions

Looks good for your playbook. Now the company just needs to deliver. If the numbers and outlook align with what I assume, I’m not worried about...
21 hours ago
by Juha Kinnunen
31
This seems to be going right according to my playbook , it’s probably also a minor relief for @Juha_Kinnunen that the market is finally starting...
23 hours ago
by NukkeNukuttaja
12
At the top of the exchange’s trading volume in the morning was health tech company Revenio, whose share jumped 8.6 percent upon the market’s...
yesterday
by Pyylevä
27
What’s going on here, given the large volume in yesterday’s closing auction and the sharp rise today? Has there been some sort of block trade...
yesterday
by First Timer
2
Here is Juha’s preliminary company report ahead of Revenio’s Q2 earnings release on Tuesday, September 8th We reiterate our buy recommendation...
8/31/2026, 5:58 AM
by Sijoittaja-alokas
10
The directed share issues related to the transaction have already been completed, and they have increased the number of shares to approximately...
8/30/2026, 2:12 PM
by Rellibs
7
The rights offering aims to raise 80 million from shareholders, and there are currently about 26.7 million shares. Thus, approximately 3 euros...
8/30/2026, 12:00 PM
7